Based on the assessment of our batch documentation review, lenstec can confirm that all procedures in the manufacturing and packaging of the device were conducted correctly.Additionally, we have not received any other complaints from this batch.There was no evidence to suggest that any aspect of this device was responsible for the reported anterior chamber fibrous exudation and increased intraocular pressure.Furthermore, the patient has recovered.The assessment by lenstec's medical monitor stated that since the anterior fibrosis has resolved, this suggests that the origin may have been systemic or ocular.Lenstec confirms that the lens, its design and the manufacturing process are not at fault due to the extensive testing that we have performed on this model.
|